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1. Introduction 
Most eucaryotic cellular and viral messenger RNAs 
(mRNAs) contain a unique 5’-terminal structure 
m7G(5’)ppp(5’) L. . . This ‘cap’ serves to protect the 
mRNA against inactivation by exonucleases and 
participates in mRNA-dependent initiation of trans- 
lation [ 11. Studies using reovirus and vesicular 
stomatitis virus mRNAs have demonstrated, for these 
mRNAs, a complete dependence on the presence 
of a 5’ ‘cap’ for in vitro translation in a wheat germ 
cell free extract and for interaction with ribosomes to 
form an mRNA-ribosome initiation complex [2,3]. 
In addition, chemical removal of the m7G(5’)ppp 
terminus from a number of ‘capped’ mRNAs by perio- 
date oxidation and aniline mediated /3-elimination 
resulted in a strong curtailing of messenger function 
[4]. In contrast with these data, however, is the 
evidence that the RNAs of several viruses, e.g., polio- 
virus, encephelomyocarditis virus and satellite tobacco 
necrosis virus (STNV) all lacking the 5’ cap, [5-91 
are fully functional in protein synthesis [6,10-131. 
A possible explanation of these results is that there 
are two intrinsically different types of mRNA, one 
type btilizing a 5’ ‘&p to facilitate its attachment to 
ribosomes and another type that utilizes solely an 
internal initiating site. To examine this question we 
have used a crude extract from vaccinia virus which 
has been demonstrated to contain ‘capping’ activity 
[ 141, to synthesize in vitro a 5’-terminal cap on STNV 
RNA. This has allowed a direct comparison of the in 
vitro initiation activity of capped and noncapped 
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STNV RNA. In addition we have compared the 
relative in vitro rates of initiation of the capped RNA 
from tobacco mosaic virus (TMV) with the capped 
and noncapped STNV RNAs. 
2. Materials and methods 
2.1. Preparation of 14C internally-labeled STNV RNA 
STNV RNA (200 pg) [ 151, was uniformly labeled 
by incubating for 45 min at 37°C with 4 ~1 (14CH3)2- 
SO4 [6.25 mCi/ml; spec. act. 13.3 pCi/mol] in 0.1 ml 
0.1 M EDTA, pH 7. The RNA was freed of unreacted 
(14CH3)2S04 on Sephadex G 25 (in 0.2 M KCl, 20 mM 
Tris-chloride, pH 7.6) and precipitated with 2.5 vol. 
ethanol. The precipitate was washed with 70% ethanol, 
30 mM potassium acetate, dried under Nz and dissolved 
in water. The RNA was recovered intact (see fig.lA) 
in 80-90% yield at a specific radioactivity of 
1600-2200 cpm/pg. 
2.2. Preparation of radioactive capped STNV RNA, 
guanylated STNV RNA and methylated TMV 
RNA 
Unlabeled STNV RNA, TMV RNA, or 14C internally- 
labeled STNV RNA were incubated for 20 min at 37°C 
in a 1 ml reaction mixture containing 50 mM Tris 
chloride pH 7.6,2 mM GTP, 1 mM dithiothreitol, 
2 mM MgC12, 1 PCi S-adenosyl [methyL3H]methionine 
(8.9 Ci/mmol) and 50 ~1 vaccinia enzyme extract [ 141. 
Wheat tRNA [16], 50 pg, were added and the reaction 
mixture was extracted twice with EDTA-washed 
phenol and precipitated with 2.5 vol. ethanol. The 
STNV RNA preparations were then fractionated by 
centrifuging through a 5-2 1% sucrose gradient in 100 
North-Holland Publishing Company - Amsterdam 
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Fig.lA. STNV [“‘C]RNA (10 500 cpm) 6 pg, labeled with 
(“YZH,),SO, were mixed with 50 /lg untreated STNV RNA 
and centrifuged through a 5-210/C sucrose gradient in a Spinco 
SW50.1 rotor for 16 h at 35 000 rev/min. The gradient was 
monitored A,,, and fractions were collected and analyzed 
for radioactivity. Fig.lB. STNV [14C]RNA 8 pg, enzymatically 
capped with S-adenosyl[methyl-3H]metl~ionine (38 900 cpm 
‘H and 11 400 cpm ‘%Z) were fractionated as in fig.lA. 
mM NaCl, 10 mM Tris acetate, pH 7.6,2 mM disodium 
EDTA for 16 h at 35 000 rev/mm in a Spinco SW50.1 
rotor. Gradients were collected as in fig.lB and the 
tubes containing 3H radioactivity were pooled and 
precipitated with 2.5 vol. ethanol. These RNAs were 
used in all experiments except for those of table 1 
where unfractionated capped RNA was used. The 
extent of capping of STNV RNA and of methylation 
of TMV RNA was determined by filtering aliquots of 
the initial reaction mixture on DEAE-filter discs and 
removing the nonadsorbed radioactivity by washing 
[14]. With STNV RNA at 30 pg/ml, the extent of 
capping was 70-80%, while at 50 pg/ml, 40-55% 
capping was obtained. With TMV RNA at 50 pg/ml, 
a lower level of enzyme extract (20 Ml/ml) was added 
and 80% methylation was obtained. The theoretical 
level for 100% capping of STNV RNA (mol. wt 
400 000) was determined on the basis of 2 mol. 
methyl/mol/RNA (11 200 cpm/pmol) and that for 
metbylation of TMV RNA (mol wt 2 X 106) on the 
basis of 1 methyl/RNA (5600 cpm/pmol). For prepa- 
ration of guanylated STNV RNA, S-adenosylmethio- 
nine was omitted, 4 units of yeast pyrophosphatase 
(Sigma) were added, and either [3H]GTP (2 mCi at 
3 X 10m7 M) with unlabeled STNV RNA or unlabeled 
GTP (2 X 1 OT6 M) with U-i4C-labeled STNV RNA, 
were added in the incubation. The extent of guanyl- 
ation in the preparation with [jH]GTP could not be 
determined directly on a DEAE-filter since a control 
incubation with RNA omitted gave very high 3H reten- 
tion. Instead, the guanylation incubation mixture was 
put through a column of Sephadex G 25 and the 
excluded volume was phenol extracted, fractionated 
on a gradient just as for the capped STNV RNA, and 
precipitated with ethanol. At this stage, one aliquot 
of the solution was counted in the usual manner on a 
DEAE-filter and gave total 132 200 cpm. A second 
aliquot treated similarly after incubation with Pl 
nuclease gave a total of 25 600 cpm. The amount of 
recovered STNV RNA was assumed to be 30 pmol 
(based on the average yield of a number of similar 
isolations of capped STNV RNA) giving a spec. act. 
3560 cpm/pmol (i.e., 132 200-25 600/30) for the 
guanylated STNV-RNA. Direct counting of the 
[3H]GTP used in the incubation mixture gave 6.7 X lo3 
cpm/pmol. The product obtained was therefore 53% 
guanylated (3560/6700). 
2.3. Ribosome binding assay 
The incubation mixture contained 20 mM KCl, 70 
mM potassium acetate, 2.3 mM magnesium acetate, 
3 mM dithiothreitol, 80 PM spermine, 30 GM L-methio- 
nine, 1 mM ATP, 20 PM GTP, 8 mM creatine phosphate, 
40 pug/ml creatine phosphate kinase, 20 mM Hepes 
buffer, pH 7.6, 200 PM sparsomycin, 15 ~1 or 40 ~1 
S23 [ 121, and radioactive mRNA in 100 ~1. After the 
appropriate incubation, 150 ~1 100 mM KCl, 20 mM 
Tris acetate, pH 7.6, 5 mM MgAcz were added and 
the solution was centrifuged through a 1 O-30% glyc- 
erol gradient in 100 mM KCl, 20 mM Tris acetate, pH 
7.6, 5 mM Mg acetate in a Spinco SW50.1 rotor for 
75 min at 49 000 rev/min. The gradient was monitored 
A *s4 nm and the various fractions were filtered through 
cellulose acetate filters. The filters were washed with 
the gradient buffer and counted. The data presented 
are the sum of the radioactivity bound in the peak 
tubes corresponding to the 80 S ribosomes. With 
TMV [3H] RNA (fig. 2B), radioactivity was found in 
tubes beyond the 80 S ribosome peak at longer times 
of incubation. Since this RNA may be dicistronic [17], 
this radioactivity was included in the data for 80 S 
ribosome binding. The input levels of mRNA in the 
119 
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Fig.2A. The ribosome binding assay was carried out with 40 
~1 S23 with reaction mixtures transferred to ice at the times 
indicated. The capped STNV RNA preparation was a l“C- 
labeled STNV RNA that was enzymatically capped in the 
usual manner with S-adenosyl [methyl-“Hlmethionine to an 
extent of 30%. The uncapped STNV RNA was carried through 
a procedure identical to that of the capped STNV RNA except 
that S-adenosyl methionine was omitted (see text). The data 
for the capped STNV RNA are the 3H radioactivity bound to 
80 S ribosomes while that for the noncapped STNV RNA are 
the 14C radioactivity bound. Since the capped STNV RNA 
also contained considerable noncapped STNV RNA, the 
binding of its “‘C radioactivity (data not shown) fell at points 
between the two curves. Fig.ZB. The standard ribosome 
binding assay was carried out with 15 ~1 S23 and 0.5 pmol 
either of 56% capped STNV or 72% methylated TMV RNA. 
different experiments refer to the particular labeled 
moiety rather than amounts of intact mRNA. This is 
explained more fully in the text. Much of the data is 
presented as percent maximum binding, the latter 
figure being routinely obtained from an incubation for 
20 min at 25°C. 
3. Result 
3.1. Ribosome binding of capped and noncapped 
STNV RNA 
Incubation of STNV RNA with S-adenosyl 
[methyL3H]methionine, GTP and crude extract from 
vaccinia virus results in the capping of the RNA [ 141. 
Table 1 presents data showing that a substantial frac- 
tion of the capped STNV RNA can be bound to 80 S 
Table 1 
Binding of capped and uncapped STNV RNAs 
S23 80 S radioactivity 
011) (So input) 
3HCapped STNV RNA 15 20 
3126 cpm 40 41 
Noncapped-STNV [ r4C]RNA 15 4 
2100 cpm 40 16 
Unfractionated capped STNV RNA (approx. 1 ng total 
STNV RNA - see Materials and methods and STNV [“Cl RNA 
(approx. 1 pg - not incubated with the vaccinia extract) were 
incubated in the standard ribosome binding assay for 10 min at 
25°C. 
ribosomes. With 40 ~1 wheat germ extract (S23), 16% 
of the noncapped STNV RNA and 4 1% of the capped 
STNV RNA are associated with an 80 S ribosome 
complex. Analysis of the capped product on a linear 
sucrose gradient (fig. 1 B) indicated that the RNA had 
undergone considerable cleavage. Since the radioactive 
methyl label is present only in the 5’terminal nucleo- 
tide [ 141, and since 5’ fragments bind efficiently to 
ribosomes (table 1, ref. [ 1 S]) we used this preparation 
to study the effect of capping on the binding of the 
RNA to ribosomes. For quantitative comparison, the 
noncapped STNV RNA was incubated with the 
vaccinia enzyme exactly as for the capped RNA except 
that GTP and S-adenosyl methionine were omitted and 
an identical fraction corresponding to the 3H peak 
(see fig.lB) was taken from both preparations. The 
data were determined as the relative rates of binding 
by ascertaining the binding at early time points in 
terms of the percent maximal binding. A kinetic 
analysis is shown in tig.2A. The binding of capped 
STNV RNA is 90% complete in 2 min whereas the 
reaction with the noncapped RNA is only 40% 
complete under the same conditions. Calculation of 
the initial rates from a number of such experiments 
resulted in the conclusion that capped STNV RNA 
binds at a rate 2.1-2.5times that of the noncapped 
STNV RNA. Because of the low specific activity of 
the 14C internally-labeled STNV RNA these experi- 
ments were performed using a saturating level of 
S23, i.e., 40 ~1. In more limited experiments using a 
low level of S23, i.e., 15 ~1, the relative rate of 
binding was also two times greater with the capped 
STNV RNA (see table 3). 
120 
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3.2. Comparison of the binding of capped STNV RNA 
and TMV RNA 
In addition to adding the m7Gppp . . . cap at the 5’ 
end of STNV RNA, the vaccinia extract also methylates 
the ribose attached to the penultimate base resulting in 
two methyl groups introduced for each modified STNV 
RNA [ 141. With an RNA that is already capped such 
as TMV RNA [19,20], methylation still occurs at the 
penultimate position [ 141. We therefore prepared 
capped (and methylated) STNV RNA and methylated 
TMV RNA, both methyl-labeled only at the 5’-terminus, 
and compared the time course of their binding to 
ribosomes. The data (fig.2b) show that the rate of 
binding of TMV RNA is only 1.3 times that of capped 
STNV RNA. Since the experiment is done with a 
limiting level of S23 (15 gl), these results represent a 
maximal difference between the two capped mRNAs. 
Capping of STNV RNA apparently brings its potential 
for ribosome binding to almost the same level as that 
of an RNA that is normally capped. 
As an alternative approach to ascertain the contri- 
bution of the 5’ cap to the binding of STNV RNA, 
we studied the effect of the analog, pm7G [ 10,12,21] 
on the formation of the 80 S complex. Table 2 shows 
that binding of capped STNV RNA is inhibited 64% 
by the analogue in the presence of 40 ~1 S23 and 78% 
with 15 ~1 S23. Binding of TMV RNA is inhibited to 
essentially the same extent as that of capped STNV 
RNA. 
3.3. Ribosome binding of guanylated STNV-RNA 
Since the vaccinia extract introduces both a 
GPPP . . . as well as two methyl groups at the 5’ end 
of STNV RNA [ 141, it was of interest to ascertain 
whether guanylation per se might result in an increased 
rate of ribosome binding. Table 3, exp. 1, presents 
Tabe12 
Inhibition of the binding of capped STNV RNA and TMV RNA by pm7G 
80 S radioactivity (cpm) Inhibition 
Control pm’G (0.5 mM) (%) 
1. 40 /JI S23: 
“H-Capped STNV RNA 
0.75 pmol - 8350 cpm 3058 1102 64 
Noncapped-STNV [ 14C] RNA 
1.7 pmol - 1425 cpm 136 92 33 
TMV-[ Q]RNA 
0.5 pm01 - 2000 cpm 1160 368 69 
2. 15 ~1 S23: 
‘H-Cappea STNV RNA 
0.38 pmol - 4225 cpm 631 138 78 
[ ‘H]Guanylated STNV RNA 
2.1 pmol - 7462 cpm 176 137 22 
TMV-[ ‘H] RNA 
0.48 pmol - 1920 cpm 442 87 80 
The incubations were 2 min at 25°C in exp 1 and 2 min at 20°C in exp. 2. The 
capped STNV RNA was 70% capped giving 1.05 pmol and 0.54 pmol total STNV 
RNA in the two experiments. The [ 3H]guanylated STNV RNA was 53% guanyl- 
ated and thus this incubation contained 4.0 pmol total STNV RNA. In another 
experiment, with a l/3 level of the [‘Hlguanylated RNA (0.67 pmol guanylated, 
total 1.3 pmol) and 40 ~1 S23, similar results (20% inhibition) were obtained. The 
assumption that guanylated STNV RNA is equivalent to noncapped STNV RNA is 
documented in the data of table 3 
121 
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ribosome-binding data for capped and guanylated 
STNV RNAs under linear (2 min, 20°C) and maximal 
conditions (20 min, 25°C). The data show that capped 
STNV RNA binds at a rate at least twice that of 
guanylated STNV RNA. A further demonstration that 
guanylation per se does not affect the reactivity of 
STNV RNA was obtained in an experiment in which 
STNV[r4C]RNA was incubated with vaccinia extract 
in the presence and absence of 2 X 10e6 M unlabeled 
GTP. Although the extent of guanylation was not 
determined, it almost certainly exceeded the 53% 
obtained in the preparation in which [3H] GTP was 
added at 0.3 X 1O-6 M. Binding of the two STNV[14C] 
RNAs was compared at 15 ~1 S23 and 40 ~1 S23 and 
found to be essentially identical (table 3, exp. 2). 
Guanylation of STNV RNA thus has no effect on 
binding capacity. 
3.4. Extent of binding of capped and uncapped STNV 
RNAS 
To ascertain whether there are specific sites on the 
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Table 3 
Relative rates of binding of capped, guanylated and unmodified STNV RNAs 
80 S Radioactivity (cpm) %j at 2 min 
2 min 20°C 20 min 25°C 
1. 15 ~1 S23: 
‘HCapped STNV RNA 
0.75 pmol - 8400 cpm 1939 3312 59 
3.0 pmol ~ 33 600 cpm 4914 11 560 43 
[ ‘II]Guanylated STNV RNA 
0.48 pmol -- 1700 cpm 91 348 26 
1.9 pm01 - 6800 cpm 196 719 27 
2. 15 ~1 S23: 
Unmodified STNV[ “‘C]RNA 89 282 31 
Guanylated STNV [ 14C] RNA 91 264 34 
2b.40 /.d S23: 
Unmodified STNV [ “Cl RNA 196 492 40 
Guanylated STNV[ Y]RNA 206 468 44 
In exp. 1, the STNV RNA was 68% capped and thus the two incubations had 1.1 
pmol and 4.4 pmol, respectively, of total STNV pmol RNA. The [ 3H]guanylated 
STNV RNA was 53% guanylated giving a total of 0.9 pmol and 3.6 pmol, respec- 
tively. In exp. 2,s pmol STNV [ 14C] RNA (3270 cpm) were added in all the incu- 
bations. The unmodified STNV [“‘C]RNA was carried through a mock guanylation 
procedure except that GTP was omitted (see text and Materials and methods). The 
standard binding assays were carried out for 2 min at 20°C and for 20 min at 25”C, 
the latter point serving as a measure of the maximal binding of the particular RNA 
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ribosome which recognize only capped STNV RNA, 
we determined the binding (10 min, 25°C) of 3H-capped 
STNV RNA in reaction mixtures that had been prein- 
cubated for 5 min at 25°C with different levels of non- 
capped STNV RNA. The control incubation (15 ~1 
S23, no RNA added during the preincubation) 
incorporated into the 80 S complex 1275 cpm from 
an input of 0.26 pg (7240 cpm) of 60% 3H-capped 
STNV RNA (0.43 pg total STNV RNA). If 2 pg or 
4 pg noncapped STNV RNA were added in the prein- 
cubation, the subsequent binding of the 3H-capped 
STNV RNA was reduced to 212 cpm and 110 cpm, 
respectively. We conclude that the ribosome binding 
sites are equivalent, with no specificity for capped or 
noncapped RNA. 
4. Discussion 
The demonstration that capped STNV RNA binds 
to ribosomes at a rate 2-2.5 times that of noncapped 
Volume 83, number 1 FEBS LETTERS November 1977 
STNV RNA (fig.2A, table 3) and the considerably 
greater inhibition by the analog, pm7G, of the binding 
of capped STNV RNA, clearly indicate that STNV 
RNA does not differ qualitatively from other mRNAs 
that are normally found in the capped form. General- 
izing from this situation, we tentatively conclude that 
the uniqueness of mRNAs that function in vivo without 
a cap is not due either to their inability to serve as 
substrates for the capping enzymes, nor to structural 
differences that would result in an unfavorable posi- 
tioning of the cap relative to the ribosome. Why such 
RNAs are not capped in vivo remains an interesting 
question. 
The analogue, pm7G, inhibits the ribosome binding 
of both capped STNV RNA and TMV RNA to 70-80%. 
Assuming that the residual binding of these mRNAs is 
largely a measure of their activity in the absence of a 
cap, the data suggest hat noncapped TMV RNA would 
function at a rate 20-30% that of capped TMV RNA. 
In experiments comparing the translational activity of 
chemically uncapped (periodate oxidized and fl-elimi- 
nated) TMV RNA with an appropriate control, we 
obtained similar results, i.e., a translational rate 20-30% 
that of the control (R. Roman, unpublished observa- 
tion). We therefore conclude that TMV RNA and 
STNV RNA, like BMV RNA 4 [22], have considerable 
translational activity in the absence of the 5’ cap and 
thus differ from reovirus and vesicular stomatitis virus 
RNAs [23]. It has been suggested [23] that the increased 
dependence of these latter mRNAs on the 5’ cap is 
related to the use of the heterologous wheat germ sys- 
tem for translation. We have found, however, that 
translation of poly A(+) RNAs from wheat embryo 
polyribosomes is inhibited by 95% in the presence 
of 0.5 mM m7G5’p @. Herson, unpublished observa- 
tion), indicating that the homologous mRNAs are 
strongly dependent on the 5’ cap. The difference 
between the mRNAs is therefore probably related to 
the accessibility of internal mRNA binding sites to the 
initiating system. 
Several studies [23,24] have indicated that capped 
and noncapped mRNA differ not only in the rate of 
binding to ribosomes but also in the extent of maxi- 
mum binding of the mRNAs. In the present study 
(table 3, exp. 1) we note similarly that the maximum 
binding of noncapped STNV RNA is 50% that of 
capped STNV RNA. That this conclusion is not cor- 
rect is evident from the experiment in which the 
binding of 3H-capped STNV RNA was almost com- 
pletely inhibited by prebinding excess noncapped 
STNV RNA. We suggest hat the discrepancy is a tech- 
nical consequence of the use of limiting levels of 
mRNA in the time course assays. Diminished maximal 
binding would result from the reduced rate of binding 
of the noncapped form coupled with the continual 
breakdown of the mRNA. 
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